Dr Tomasz Lukaszewski

Dr Tomasz Lukaszewski is a fertility specialist with extensive experience in Obstetrics & Gynaecology practising within busy tertiary teaching hospitals in Poland and the UK, as well as independently in private outpatient clinics. His wide-ranging training and level of experience has allowed him to join the Specialist Register of Obstetrics & Gynaecology, recognised within all EU countries.

In 2018, Dr Lukaszewski commenced work in the NHS within the Reproductive Medicine Unit at University College London Hospitals (UCLH). He developed a special interest in the management of endometriosis including minimal access surgery at The Royal London Endometriosis Centre. In 2020, he became a Clinical Fellow in Reproductive Medicine and Minimal Access Surgery at UCLH.

He has presented nationally and internationally at fertility conferences, including the British Fertility Society (BFS) and European Society of Human Reproduction and Embryology (ESHRE). He is also a member of the British Society for Gynaecology Endoscopy (BSGE) where he taught courses at the Royal College of Obstetrician and Gynaecology (RCOG).

• 2015 – 2018: Lecturer in Obstetrics & Gynaecology at Poznan University of Medical Sciences.

Publications:

1. Effectiveness of modified downregulation for women with moderate and severe adenomyosis of the uterus prior to frozen thawed embryo transfer (MODA) study protocol: a pragmatic randomised-controlled trial. Latif S, Wattar BHA, Balachandren N, Lukaszewski T, Saridogan E, Yasmin E, Serhal P, Mavrelos D. BMJ Open. 2021 Oct 29; 11(10): e050248. doi: 10.1136/bmjopen-2021-050248. PMID: 34716161; PMCID: PMC8559114.
2. Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study. Emil Lou, Rachel I Vogel, Spencer Hoostal, Phillip Wong, Aaron Grad, Minnu Monu, Tomasz Lukaszewski, Jaai Deshpande, Elizabeth L Dickson, Molly Klein, Michael A Linden, Subbaya Subramanian, Deanna Teoh, Melissa A Geller, Oncologist 2019 Nov; 24(11): 1422-e1013
3. Assessment of Circulating Tumor Cells as a Predictive Biomarker of Histology in Women With Suspected Ovarian Cancer. Lou E, Vogel RI, Teoh D, Hoostal S, Grad A, Gerber M, Monu M, Lukaszewski T, Deshpande J, Linden MA, Geller MA. Lab Med. 2018 Mar 21; 49(2): 134-139
4. The evaluation of the predictive value of TNF-alpha concentration in maternal serum in the prediction of neonatal and maternal infection. Lukaszewski T, Drews K, Seremak-Mrozikiewicz A, Sieroszewski P, Barlik M, Wolski H, Wleklak M. Ginekol Pol. 2015 Jan; 86(1): 26-32.
5. The evaluation of the predictive value of TNF-alpha concentration in maternal serum in the prediction of neonatal and maternal infection. Lukaszewski T, Drews K, Seremak-Mrozikiewicz A, Sieroszewski P, Barlik M, Wolski H, Wleklak M. Ginekol Pol. 2015 Jan; 86(1): 26-32.
6. Il-6 level before and after delivery in women with PPROM as a predictive marker of neonatal infection. Tomasz Lukaszewski, Krzysztof Drews, Agnieszka Seremak-Mrozikiewicz, Piotr Sieroszewski, Grazyna Kurzawinska, Magdalena Barlik, Marzena Wleklak. Perinat. Neonat. Ginek., 2013 : T. 6, nr 2, s. 81-87.
7. Conservative treatment of endometriosis. Drews K, Barlik M, Lukaszewski T. Ginekol Pol. 2012 Mar; 83(3): 209-13.
8. Concentration of selected cytokines in women with premature rupture of membranes and preterm delivery: preliminary study. Seremak-Mrozikiewicz A, Lorenc A, Barlik M, Lukaszewski T, Sieroszewski P, Krasnik W, Drews K. Ginekol Pol. 2011 Aug; 82(8): 576-84.
9. Hormonalne uwarunkowanie porodu [Hormonal pathways of labour]. Krzysztof Drews, Tomasz Lukaszewski. Endokrynopatie w ciazy [Endocrinopathies in pregnancy]. Anhelly Syrenicz. Szczecin: Wydaw. Pom. Uniw. Med. w Szczecinie, 2011; s. 365-375.
10. Lozysko przodujace [Placenta praevia]. Chapter in OG-BYN manual. Krzysztof Drews, Wojciech Pienkowski, Tomasz Lukaszewski, Agnieszka Seremak-Mrozikiewicz. Ciecie cesarskie (Caesarean Section). Zbigniew Slomko, Krzysztof Drews, Ryszard Poreba. Pol. Tow. Ginekol. 2011; 339-344.
11. The cost-effectiveness of elective cesarean delivery in prevention of perinatal transmission HIV and HSV infections. Zbigniew Slomko, Krzysztof Drews, Agnieszka Seremak-Mrozikiewicz, Tomasz Lukaszewski. Ginek. Poloz. 2010: R. 5, nr 4, s. 20-25.
12. Cost effectiveness of vaginal birth after cesarean delivery. Zbigniew Slomko, Krzysztof Drews, Agnieszka Seremak-Mrozikiewicz, Tomasz Lukaszewski. Ginek. Poloz. 2010 : R. 5, nr 4, s. 51-56.
13. The significance of tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) gene polymprhisms in the etiology of preterm delivery. Magdalena Barlik, Tomasz Lukaszewski, Agnieszka Seremak-Mrozikiewicz, Krzysztof Drews. Perinat. Neonat. Ginek. 2010 : T. 3, nr 4, s. 249-254.
14. Sacrococcygeal teratoma in foetus-case report. Lukaszewski T, Polczynska-Kaniak E, Puacz P, Seremak-Mrozikiewicz A, Drews K. Ginekol Pol. 2009 Nov;80(11):861-4.
15. Activity of telomerase in ovarian cancer cells. Clinical implications. Lubin J, Markowska J, Markowska A, Stanislawiak J, Lukaszewski T. Clin Exp Obstet Gynecol. 2009; 36(2): 91-6.
16. Polymorphism in the genes of Toll-like receptors type 2 and type 4 (TLR-2 and TLR-4) and the risk of premature rupture of the membranes: preliminary study. Lukaszewski T, Barlik M, Seremak-Mrozikiewicz A, Kurzawinska G, Mrozikiewicz PM, Sieroszewski P, Drews K. Ginekol Pol. 2009 Dec; 80(12): 914-9.